Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: Implications for the hosts' innate immune response

Cellular Immunology

Volumn 285, Issue 1-2, 2013, Pages 100-110

  Kundu, Kiran ^a   Dutta, Kallol ^a,b   Nazmi, Arshed ^a   Basu, Anirban ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

^b CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Flavivirus; Suppressors of cytokine signaling; Type 1 interferons

Indexed keywords

INTERFERON; INTERFERON TYPE 1; JANUS KINASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; THIOGLYCOLIC ACID; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HOST; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; INHIBITION KINETICS; INNATE IMMUNITY; JAPANESE ENCEPHALITIS VIRUS INFECTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS REPLICATION;

2′-5′-OLIGOADENYLATE SYNTHETASE-LIKE; ABCE1; ATP-BINDING CASSETTE, SUB-FAMILY E PROTEIN; FLAVIVIRUS; IFIT1; IFNΑ; IFNΒ; INTERFERON ALPHA; INTERFERON BETA; INTERFERON REGULATORY TRANSCRIPTION FACTOR; INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; IRF; JAK; JANUS KINASE; JAPANESE ENCEPHALITIS VIRUS; JEV; NFΚB; NUCLEAR FACTOR KAPPA B; OASL; PERITONEAL MACROPHAGE; PKR; PMΦ; PROTEIN KINASE R; QRT-PCR; QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION; SMΦ; SOCS; SPLENIC MACROPHAGE; STAT; SUPPRESSORS OF CYTOKINE SIGNALING; TYPE-1 INTERFERONS;

ANIMALS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; IMMUNITY, INNATE; INTERFERON TYPE I; JANUS KINASES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; VIRUS REPLICATION;

EID: 84886732794     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.09.005     Document Type: Article

References (43)

1. Coffey L.L., Forrester N., Tsetsarkin K., Vasilakis N., Weaver S.C. Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol. 2013, 8:155-176.
2. Kurane I. Immune responses to Japanese encephalitis virus. Curr. Top. Microbiol. Immunol. 2002, 267:91-103.
3. Wu M.F., Chen S.T., Yang A.H., Lin W.W., Lin Y.L., Chen N.J., Tsai I.S., Li L., Hsieh S.L. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood 2013, 121:95-106.
4. Prestwood T.R., May M.M., Plummer E.M., Morar M.M., Yauch L.E., Shresta S. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J. Virol. 2012, 86:12138-12147.
5. Rios M., Zhang M.J., Grinev A., Srinivasan K., Daniel S., Wood O., Hewlett I.K., Dayton A.I. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion 2006, 46:659-667.
6. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
7. Chen X.P., Losman J.A., Rothman P. SOCS proteins, regulators of intracellular signaling. Immunity 2000, 13:287-290.
8. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature 1997, 387:917-921.
9. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997, 387:921-924.
10. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997, 387:924-929.
11. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Hara T., Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 1995, 14:2816-2826.
12. Fenner J.E., Starr R., Cornish A.L., Zhang J.G., Metcalf D., Schreiber R.D., Sheehan K., Hilton D.J., Alexander W.S., Hertzog P.J. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat. Immunol. 2006, 7:33-39.
13. Akhtar L.N., Benveniste E.N. Viral exploitation of host SOCS protein functions. J. Virol. 2011, 85:1912-1921.
14. Campbell G.L., Hills S.L., Fischer M., Jacobson J.A., Hoke C.H., Hombach J.M., Marfin A.A., Solomon T., Tsai T.F., Tsu V.D., Ginsburg A.S. Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organ. 2011, 89:766-774. 774A-774E.
15. Chen L.K., Liao C.L., Lin C.G., Lai S.C., Liu C.I., Ma S.H., Huang Y.Y., Lin Y.L. Persistence of Japanese encephalitis virus is associated with abnormal expression of the nonstructural protein NS1 in host cells. Virology 1996, 217:220-229.
16. Schmaljohn C., Blair C.D. Persistent infection of cultured mammalian cells by Japanese encephalitis virus. J. Virol. 1977, 24:580-589.
17. Mathur A., Arora K.L., Rawat S., Chaturvedi U.C. Persistence, latency and reactivation of Japanese encephalitis virus infection in mice. J. Gen. Virol. 1986, 67(Pt 2):381-385.
18. Mathur A., Bharadwaj M., Kulshreshtha R., Rawat S., Jain A., Chaturvedi U.C. Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br. J. Exp. Pathol. 1988, 69:423-432.
19. Dutta K., Kumawat K.L., Nazmi A., Mishra M.K., Basu A. Minocycline differentially modulates viral infection and persistence in an experimental model of Japanese encephalitis. J. Neuroimmune Pharmacol. 2010, 5:553-565.
20. Ravi V., Desai A.S., Shenoy P.K., Satishchandra P., Chandramuki A., Gourie-Devi M. Persistence of Japanese encephalitis virus in the human nervous system. J. Med. Virol. 1993, 40:326-329.
21. Sharma S., Mathur A., Prakash V., Kulshreshtha R., Kumar R., Chaturvedi U.C. Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children. Clin. Exp. Immunol. 1991, 85:85-89.
22. Aleyas A.G., George J.A., Han Y.W., Rahman M.M., Kim S.J., Han S.B., Kim B.S., Kim K., Eo S.K. Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J. Immunol. 2009, 183:2462-2474.
23. Dutta K., Mishra M.K., Nazmi A., Kumawat K.L., Basu A. Minocycline differentially modulates macrophage mediated peripheral immune response following Japanese encephalitis virus infection. Immunobiology 2010, 215:884-893.
24. Huang H.N., Rajanbabu V., Pan C.Y., Chan Y.L., Hui C.F., Chen J.Y., Wu C.J. Modulation of the immune-related gene responses to protect mice against Japanese encephalitis virus using the antimicrobial peptide, tilapia hepcidin 1-5. Biomaterials 2011, 32:6804-6814.
25. Nazmi A., Dutta K., Das S., Basu A. Japanese encephalitis virus-infected macrophages induce neuronal death. J. Neuroimmune Pharmacol. 2011, 6:420-433.
26. Sengupta M., Bishayi B. Effect of lead and arsenic on murine macrophage response. Drug Chem. Toxicol. 2002, 25:459-472.
27. Nazmi A., Mukhopadhyay R., Dutta K., Basu A. STING mediates neuronal innate immune response following Japanese encephalitis virus infection. Sci. Rep. 2012, 2:347.
28. Adhya D., Dutta K., Kundu K., Basu A. Histone deacetylase inhibition by japanese encephalitis virus in monocyte/macrophages: a novel viral immune evasion strategy. Immunobiology 2013, 218:1235-1247.
29. Linossi E.M., Babon J.J., Hilton D.J., Nicholson S.E. Suppression of cytokine signaling: the SOCS perspective. Cytokine Growth Factor Rev. 2013, 24:241-248.
30. Trinchieri G. Type I interferon: friend or foe?. J. Exp. Med. 2010, 207:2053-2063.
31. Kubo M., Hanada T., Yoshimura A. Suppressors of cytokine signaling and immunity. Nat. Immunol. 2003, 4:1169-1176.
32. Lin R.J., Liao C.L., Lin E., Lin Y.L. Blocking of the alpha interferon-induced Jak-stat signaling pathway by Japanese encephalitis virus infection. J. Virol. 2004, 78:9285-9294.
33. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 1998, 67:227-264.
34. Tu Y.C., Yu C.Y., Liang J.J., Lin E., Liao C.L., Lin Y.L. Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A. J. Virol. 2012, 86:10347-10358.
35. Hovanessian A.G. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2'-5' oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev. 2007, 18:351-361.
36. Lin R.J., Yu H.P., Chang B.L., Tang W.C., Liao C.L., Lin Y.L. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection. J. Immunol. 2009, 183:8035-8043.
37. Tag-El-Din-Hassan H.T., Sasaki N., Moritoh K., Torigoe D., Maeda A., Agui T. The chicken 2'-5' oligoadenylate synthetase A inhibits the replication of West Nile virus. Jpn. J. Vet. Res. 2012, 60:95-103.
38. Pichlmair A., Lassnig C., Eberle C.A., Gorna M.W., Baumann C.L., Burkard T.R., Burckstummer T., Stefanovic A., Krieger S., Bennett K.L., Rulicke T., Weber F., Colinge J., Muller M., Superti-Furga G. IFIT1 is an antiviral protein that recognises 5'-triphosphate RNA. Nat. Immunol. 2011, 12:624-630.
39. Chang T.H., Liao C.L., Lin Y.L. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect. 2006, 8:157-171.
40. Lazear H.M., Lancaster A., Wilkins C., Suthar M.S., Huang A., Vick S.C., Clepper L., Thackray L., Brassil M.M., Virgin H.W., Nikolich-Zugich J., Moses A.V., Gale M., Fruh K., Diamond M.S. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013, 9:e1003118.
41. Daffis S., Suthar M.S., Szretter K.J., Gale M., Diamond M.S. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog. 2009, 5:e1000607.
42. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734.
43. Balachandran S., Beg A.A. Defining emerging roles for NF-kappaB in antivirus responses: revisiting the interferon-beta enhanceosome paradigm. PLoS Pathog. 2011, 7:e1002165.